Financing allows investment by parties not able to participate in December, 2016 equity raise
TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it is conducting a non-brokered private placement equity financing under which it intends to issue up to 3,000,000 units at a price of $0.05 per unit for gross proceeds of up to $150,000.
Each unit will be comprised of one common share and one common share purchase warrant, exercisable for one additional share at a price of $0.075 within two years of purchase. There is no minimum offering amount. The securities to be issued under the financing will be subject to a four-month hold period. The terms of the financing are subject to the approval of the TSX Venture Exchange.
This equity financing will allow parties, who were not able to participate in the Company’s December, 2016 raise, to invest in the Company. The proceeds from the financing will be used for general operations, regulatory submissions and working capital.
